Related Experiment Video

Updated: May 26, 2026

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously

Karthick Raja Muthu Raja, Lucie Kovarova, Roman Hajek

    Leukemia & Lymphoma
    |December 28, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: May 26, 2026

    A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
    11:34

    A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

    Published on: April 11, 2025

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Differentiation of Common Myeloid Progenitor Cells01:15

    Differentiation of Common Myeloid Progenitor Cells

    Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

    Articles linked to this work by shared authors, journal, and citation graph.

    Comparison of the HemoScreen Point-Of-Care Haematology Analyser With Sysmex XN, Beckman Coulter DxH 560 and HORIBA Yumizen H550 in Patients With Abnormal Blood Counts.

    International journal of laboratory hematology·2026

    Teclistamab in relapsed/refractory Waldenström macroglobulinemia

    Haematologica·2026

    The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN).

    American journal of hematology·2026

    Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

    Blood cancer discovery·2026

    Autologous stem cell transplantation for newly diagnosed multiple myeloma - real-world data from 2,149 Czech patients.

    Haematologica·2026

    Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

    Nature medicine·2026

    Venetoclax consolidation deepens response and enables measurable residual disease-guided finite therapy in BTK inhibitor-treated chronic lymphocytic leukemia.

    Leukemia & lymphoma·2026

    Clinical outcomes of adults with PAX5-mutated or rearranged B-cell acute lymphoblastic leukemia.

    Leukemia & lymphoma·2026

    Efficacy and safety of three-drug induction-based MASPORE 2003 chemotherapy protocol in standard- and intermediate-risk pediatric acute lymphoblastic leukemia: a decade-long single-center experience from India.

    Leukemia & lymphoma·2026

    Characterizing the landscape of hospitalizations for multiple myeloma in Spain: a retrospective analysis (2016-2023).

    Leukemia & lymphoma·2026

    Diagnostic accuracy and clinical usefulness of lung ultrasound in onco hematological patients with neutropenic fever.

    Leukemia & lymphoma·2026

    Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a national cancer database analysis.

    Leukemia & lymphoma·2026

    Targeted Intracranial Delivery of Secreted Immune Molecules to Investigate Neuroimmune Interactions.

    Journal of visualized experiments : JoVE·2026

    Pilot study of Wilms tumor 1-targeted human platelet lysate-induced antigen-presenting cells in advanced solid cancer patients.

    Regenerative therapy·2026

    Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications.

    Regenerative therapy·2026

    Beyond immune suppression: regenerative programs in regulatory T cells.

    Cell insight·2026

    Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

    BMJ neurology open·2026

    DOTAM-TCB: Universal Small Molecule-guided Hapten- and T Cell-bispecific Antibodies for Cancer Immunotherapy.

    Antibody therapeutics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us